← SynDRA
EPRAZINONE
SynDRA canonical compound SYN0028008 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Mechanism of action | mucolytic agent |
|---|
| Indication | bronchospasm |
|---|
| Disease area | pulmonary |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- 5HT2A
- CP2D6
- ESR1
- ESRRA
- KCNH2
- NF2L2
- NR1I2
- NSD2
Drug classes
- Expectorants
- Respiratory System Agents
- mucolytic agent
ATC classes
- R05C · EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS
Cross-references
Synonyms
- eprazinone hydrochloride
- eprazinone HCl
- Eprazinona
- Eprazinonum
- 1-(2-Phenyl-2-ethoxyethyl)-4-(2-benzyloxypropyl)piperazine
- CHEBI:82716
- RefChem:137400
- DTXCID6028311
- R05CB04
- 1-(2-phenyl-2-ethoxy)ethyl-4-(2-benzyloxy)propylpiperazine
- MFCD00866843
- Eprazinone (INN)
- Eprazinon
- EPRAZINONE [INN]
- Eprazinone [INN:DCF]
- Eprazinonum [INN-Latin]
- Eprazinona [INN-Spanish]
- NCGC00167445-01
- EINECS 233-873-3
- BRN 0844684
- UNII-883YNL63WU
- EPRAZINONE [MI]
- EPRAZINONE [WHO-DD]
- SCHEMBL20156
- 5-23-02-00216 (Beilstein Handbook Reference)
- orb1698177
- GLXC-07796
- HY-B2078
- T3034L
- AKOS005066066
- NCGC00167445-03
- AS-73208
- DB-040504
- CS-0017484
- NS00010370
- D07902
- F15043
- SBI-0654070.0001
Look up EPRAZINONE in the interactive SynDRA portal →